Recruiting
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
NCT05784688
- Conditions
- Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +20 more
- Locations
-
- NEXT Oncology San Antonio, Texas, United States
- Hope Cancer Center Tyler, Texas, United States
- Medical Oncology Spokane, Washington, United States
- CHA University Bundang Medical Center Seongnam, South Korea